Literature DB >> 14288151

QUINIDINE-INDUCED THROMBOCYTOPENIC PURPURA.

E C STRATFORD, K R TANAKA.   

Abstract

Entities:  

Keywords:  DRUG HYPERSENSITIVITY; GERIATRICS; PURPURA, THROMBOPENIC; QUINIDINE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14288151      PMCID： PMC1515752     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


× No keyword cloud information.
  12 in total

1.  DRUG HYPERSENSITIVITY PURPURAS. REPORT OF A CASE AND DISCUSSION OF THEIR MECHANISMS.

Authors:  J W BETTMAN
Journal:  Arch Intern Med       Date:  1963-12

2.  Rapid diagnosis of drug-induced thrombocytopenic purpura. Report of three cases due to quinine, quinidine, and Dilantin.

Authors:  R M WEINTRAUB; L PECHET; B ALEXANDER
Journal:  JAMA       Date:  1962-05-19       Impact factor: 56.272

3.  Cause of drug-induced thrombocytopenic purpura identified by the passive transfer reaction.

Authors:  H BERGER
Journal:  Ann Intern Med       Date:  1962-04       Impact factor: 25.391

4.  Thrombocytopenic purpura due to quinidine.

Authors:  R J SCHEN; M RABINOVITZ
Journal:  Br Med J       Date:  1958-12-20

5.  Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

6.  Immunothrombocytopenic purpura due to quinidine; report of four new cases with special observations on patch testing.

Authors:  A L FREEDMAN; E A BRODY; P S BARR
Journal:  J Lab Clin Med       Date:  1956-08

7.  The mechanism of the reduction of clot retraction by sedormid in the blood of patients who have recovered from sedormid purpura.

Authors:  J F ACKROYD
Journal:  Clin Sci       Date:  1949-12-19       Impact factor: 6.124

8.  The cause of thrombocytopenia in sedormid purpura.

Authors:  J F ACKROYD
Journal:  Clin Sci       Date:  1949-12-19       Impact factor: 6.124

9.  Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

10.  Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.